Carl L Gordon
Director at ADARx Pharmaceuticals, Inc. (ADRX); Director at BlossomHill Therapeutics, Inc. (BLSM); Director at Electra Therapeutics, Inc. (ETRA); Director at Scribe Therapeutics, Inc. (SCTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 30SEC | ADRXADARx Pharmaceuticals, Inc. | Buy | 300,24914,325,529 held (+2%) | $17.00 | $5.1M | +4.6% |
| Sep 30SEC | ADRXADARx Pharmaceuticals, Inc. | Buy | 61,5169,292,025 held (+1%) | $17.00 | $1.0M | +4.6% |
| Sep 30SEC | ADRXADARx Pharmaceuticals, Inc. | Buy | 588,235new position | $17.00 | $10.0M | +4.6% |
| Sep 23SEC | ETRAElectra Therapeutics, Inc. | Buy | 333,3335,126,891 held (+7%) | $15.00 | $5.0M | -39.7% |
| Sep 23SEC | ETRAElectra Therapeutics, Inc. | Buy | 1,000,0001,758,279 held (+132%) | $15.00 | $15.0M | -39.7% |
| Aug 12SEC | BLSMBlossomHill Therapeutics, Inc. | Buy | 625,0002,714,279 held (+30%) | $16.00 | $10.0M | +9.3% |
| Jul 29SEC | SCTXScribe Therapeutics, Inc. | Buy | 1,000,0001,348,825 held (+287%) | $15.00 | $15.0M | +41.1% |
- Buy
Director Carl L Gordon bought $10.0M of ADRX at $17.00 — first open-market purchase in our records; opens a new position.
- Buy
Director Carl L Gordon bought $5.0M of ETRA at $15.00 — first open-market purchase in our records.
- Buy
Director Carl L Gordon bought $15.0M of ETRA at $15.00 — largest purchase by this insider in our records; raises the stake by 132%.
- Buy
Director Carl L Gordon bought $10.0M of BLSM at $16.00 — first open-market purchase in our records; raises the stake by 30%.
- Buy
Director Carl L Gordon bought $15.0M of SCTX at $15.00 — first open-market purchase in our records; raises the stake by 287%.